Description
Animal models are essential tools for studying a range of issues in preclinical and clinical research on therapies targeting cancerous tumors. As clinical trials of advances in cancer immunotherapy are predicted to outpace preclinical research in the near future, there remains an urgent need to develop better animal models for preclinical evaluation of novel modulators. Animal Models for the Development of Cancer Immunotherapy provides a detailed overview of different preclinical model systems for development of novel cancer immunotherapies while highlighting how key aspects of individual models translate into clinical findings. 309 p.
- Seng-Lai Tan, Editor. PhD. Currently Chief Scientific Officerat Immunitas Therapeutics, Waltham, MA (USA); Former Head of Immunology at Elstar Therapeutics, Cambridge, MA (USA).
- Publication date (digital version): 2022-08.
You must be logged in to submit a review.